Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-50
SponsorHacettepe University
About this trial
The aim of this study was to investigate the effects of date consumption on hedonic hunger and appetite hormones in individuals diagnosed with type 2 diabetes.The main questions it aims to answer are:
* Does date consumption reduce hedonic hunger in individuals with type 2 diabetes? * Does persimmon consumption change Ghrelin, GLP-1 and GIP concentrations in individuals with Type 2 diabetes? * Does persimmon consumption reduce HOMA-IR and HbA1c values in individuals with Type 2 diabetes? * Does consumption of persimmon reduce LDL cholesterol, total cholesterol and triglyceride concentrations in individuals with type 2 diabetes? To see the effects of date consumption on hedonic hunger and appetite hormones, the researchers will compare individuals with type 2 diabetes who consume 3 dates daily with individuals with type 2 diabetes who do not.
Participants:
* Individuals in the intervention group will consume 3 (25 g) Baghdad dates (15 g CHO) daily as part of the breakfast meal, while individuals in the control group will not consume dates. * Three interviews will be conducted with patients. * A record of blood findings and questionnaires will be kept during these interviews.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals diagnosed with Type 2 diabetes aged 19-50 years (excluding menopausal women),
Individuals with BMI between 25-35 kg/m2,
Individuals with a Nutritional Strength Scale score of 2.5 and above,
Individuals who agreed not to start taking new dietary supplements or alternative therapies during the study period,
Disqualifiers
Individuals who do not approve the volunteer consent form,
Individuals with a Nutritional Strength Scale score below 2.5,
Pregnant or breastfeeding women (or women planning to become pregnant within 3 months)
Individuals with dietary energy <800 kcal/day and >4000 kcal/day,
Trial design
Design model
Parallel
Treatments tested in this trial
3 dates at the breakfast meal in the diet program
Other interventionParticipants in the intervention group will consume 3 dates at the breakfast meal in the diet program.
Treatment groups
64 Participants
are divided into 2 treatment groupsGroup A: INTERVENTION GROUPExperimental treatment 1 intervention
Group B: CONTROL GROUPNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Appetite hormone levels
GLP-1, GIP and Ghrelin hormone levels in plasma will be measured in pg/ml.
Time frame
3 months2
Hedonic hunger levels
Hedonic hunger levels of individuals will be determined using the Power of Food Scale (PFS).
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov